[144] Doximity, Inc. SEC Filing

Rhea-AI Filing Summary

A shareholder of DOCS has filed a Form 144 notice to sell up to 10,000 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE. The planned sale has an aggregate market value of $500,000, and the filing notes that 137,373,858 shares of common stock are outstanding.

The 10,000 shares to be sold were acquired on 11/21/2025 via a stock option exercise from the issuer, paid in cash on the same date. Over the prior three months, the same seller, Timothy Cabral, reported sales of 20,000 shares of common stock on 09/24/2025 for gross proceeds of $1,500,000 and 6,360 shares on 09/02/2025 for gross proceeds of $421,655.28.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	10000	500000.00	137373858	11/21/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/21/2025	Stock Option Exercise	ISSUER			10000	11/21/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
TIMOTHY CABRAL 500 3rd Street Ste 510 San Francisco CA 94107	Common	09/24/2025	20000	1500000.00
TIMOTHY CABRAL 500 3rd Street Ste 510 San Francisco CA 94107	Common	09/02/2025	6360	421655.28

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the DOCS Form 144 filing report?

The Form 144 reports that a DOCS shareholder intends to sell up to 10,000 shares of common stock with an aggregate market value of $500,000 on the NYSE.

How many DOCS shares are planned for sale under this Form 144 and at what value?

The filing covers a planned sale of 10,000 DOCS common shares with an aggregate market value of $500,000.

How were the 10,000 DOCS shares being sold acquired?

The 10,000 shares were acquired on 11/21/2025 through a stock option exercise from the issuer, with the purchase price paid in cash on that date.

Which broker is handling the DOCS Form 144 sale and on which exchange?

The planned sale is through Morgan Stanley Smith Barney LLC Executive Financial Services, with trading on the NYSE.

How many DOCS shares are outstanding according to the Form 144?

The filing states that there are 137,373,858 shares of DOCS common stock outstanding.

What DOCS share sales has the seller made in the past 3 months?

The seller, Timothy Cabral, reported selling 20,000 common shares on 09/24/2025 for $1,500,000 and 6,360 common shares on 09/02/2025 for $421,655.28.

What representation does the seller make in the DOCS Form 144?

By signing the notice, the seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.